Physician profile
Will Choi
NPI 1740803717
$834.03
in general payments reported to CMS, 2019-2025
14 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $309 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $169.79 | 2024-2025 | Crysvita |
| Corcept Therapeutics | $130.58 | 2024-2025 | Korlym |
| Amgen INC. | $108.06 | 2024-2025 | Repatha, Evenity, Prolia |
| Xeris Pharmaceuticals, INC. | $73.72 | 2025 | Recorlev |
| Recordati_rare_diseases_inc. | $60.76 | 2024-2025 | Isturisa, Signifor Lar |
| Sanofi-Aventis U.S. LLC | $60.71 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $56.21 | 2025 | Tlando |
| Dexcom, INC. | $40.00 | 2024 | Dexcom G6 Transmitter |
| Insulet Corporation | $34.45 | 2025 | Omnipod |
| Takeda Pharmaceuticals U.S.A., INC. | $23.67 | 2025 | Eohilia |
| Soleno Therapeutics, INC. | $22.48 | 2025 | Vykat Xr |
| Bayer Healthcare Pharmaceuticals INC. | $21.32 | 2025 | |
| Lilly USA, LLC | $16.26 | 2025 | |
| Tandem Diabetes Care, INC. | $16.02 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Will Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.